ERBB2 and neoplasm: The benefit of using AI was particularly notable in the scoring of HER2 IHC 1+ tumours, where it improved concordance from 25.7% (9/35; Fleiss kappa 0.242) to 68.9% (42/61; Fleiss kappa 0.687).29